Search Results - "de Raaf, Michiel A."
-
1
Imatinib in patients with severe COVID-19: a randomised, double-blind, placebo-controlled, clinical trial
Published in The lancet respiratory medicine (01-09-2021)“…The major complication of COVID-19 is hypoxaemic respiratory failure from capillary leak and alveolar oedema. Experimental and early clinical data suggest that…”
Get full text
Journal Article -
2
Nintedanib improves cardiac fibrosis but leaves pulmonary vascular remodelling unaltered in experimental pulmonary hypertension
Published in Cardiovascular research (01-02-2019)“…Abstract Aims Pulmonary arterial hypertension (PAH) is associated with increased levels of circulating growth factors and corresponding receptors such as…”
Get full text
Journal Article -
3
DNGR1-Cre-mediated Deletion of Tnfaip3 /A20 in Conventional Dendritic Cells Induces Pulmonary Hypertension in Mice
Published in American journal of respiratory cell and molecular biology (01-11-2020)“…Chronic perivascular inflammation is a prominent feature in the lungs of idiopathic pulmonary arterial hypertension. Although the proportions of conventional…”
Get full text
Journal Article -
4
Placental effects and transfer of sildenafil in healthy and preeclamptic conditions
Published in EBioMedicine (01-07-2019)“…The phosphodiesterase-5 inhibitor (PDE5) sildenafil has emerged as a promising treatment for preeclampsia (PE). However, a sildenafil trial was recently halted…”
Get full text
Journal Article -
5
Agrobacterium-mediated gene transfer and enhanced green fluorescent protein visualization in the mycorrhizal ascomycete Tuber borchii: a first step towards truffle genetics
Published in Current genetics (01-07-2005)“…Mycorrhizal ascomycetes are ecologically and commercially important fungi that have proved impervious to genetic transformation so far. We report here on the…”
Get full text
Journal Article -
6
Placental effects and transfer of sildenafil in healthy and preeclamptic conditionsResearch in context
Published in EBioMedicine (01-07-2019)“…Background: The phosphodiesterase-5 inhibitor (PDE5) sildenafil has emerged as a promising treatment for preeclampsia (PE). However, a sildenafil trial was…”
Get full text
Journal Article